Other Articles
#1 in Business Subscribe Email Print

You are here: Home > Business > Management > Commitment: A Door to Open

Tags

  • process
  • regulatory
  • device
  • biological product
  • developing combination

  • Links

  • The City of Halifax
  • House Rules For Dogs
  • YPN Vs. Adsense -- Adsense Showing Yahoo Up
  • Other Articles - Commitment: A Door to Open

    Is commitment something you gain on the way, or do you need it right from the
    According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
    start?

    Many projects and business activities fail because of a lack of comm
    ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

    Examples of combination products may in
    itment. Some of these activities stop halfway others near the end – when most
    lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

    commitment is needed – and others do not even get really started. It?s all i
    here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
    the emotion around it. People can be sceptic at first, they are insecure (I
    d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

    Combination pro
    know I am) and they wait what others do before they step in.

    Even in persona
    ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
    l relations you cannot do without commitment. Or put it another way; personal
    easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
    relations are relations because of the commitment. You said ?yes? at one poi
    nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
    t at time. It is possible that commitment fades away down the road. But this
    and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
    is another topic. Any relation starts after commitment.

    Commitment is not so
    ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
    mething you gain over a period of time. You need it at day one. Project manag
    ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

    Following aspects would a
    ers know this and the first step they take in accepting (an existing or new)
    dd to the challenges in developing combination products:

    Which markets to tap where the combination products can do fairly well?
    Which combination prod
    roject is to check the commitment as part of an intake. They know whether a p
    cts are meaningful and rational?
    Which therapeutic categories to select?
    Which Combinations can address unmet needs of the patients?
    Do combin
    roject is viable or not.

    What you should never do is, if you reckon that the
    tions increase the patient compliance?
    What would be the developing cost?
    How to tackle the risks encountered during combination product developmen
    re is no commitment, try and pull or push in the hope you will receive it soo
    t?

    As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
    n. You should rather start with it. Commitment is like a door that should ope
    ping new procedures for reviewing their safety, efficacy and quality.

    Professional from academic institutions, pharmaceutical industries, health care indust
    . And if it doesn’t you have a problem. This is where sales comes in. Sales r
    y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
    epresentatives know how to deal with this aspect. They might give something a
    .

    As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
    way to let you feel good. After which the barrier should fall. The door gets
    elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

    Companies that provide selfless information through particip
    open, and you are a guest, welcome to come in.

    © 2005 Hans Bool / Astor Whit


    tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

    HTTP = HTML link (for blogs, profiles,phorums):
    <a href="http://www.otherarticles.org.ua/article/23510/otherarticles-Commitment-A-Door-to-Open.html">Commitment: A Door to Open</a>

    BB link (for phorums):
    [url=http://www.otherarticles.org.ua/article/23510/otherarticles-Commitment-A-Door-to-Open.html]Commitment: A Door to Open[/url]

    Related Articles:

    Writing a Successful Radio Commercial

    How To Find A Job After Graduate School

    Keeping Your Cool When The Customer Gets Hot

    Bookmark it: del.icio.us digg.com reddit.com netvouz.com google.com yahoo.com technorati.com furl.net bloglines.com socialdust.com ma.gnolia.com newsvine.com slashdot.org simpy.com shadows.com blinklist.com